how long have glp-1 drugs been around Approved 20 years ago as a diabetes treatment, found to help patients reduce weight, changing the lives of more than 30 million people in the U.S. But there GLP-1 Drugs and Type 1

Kukat et al., 2015)

Key Takeaways Gradual dose escalation over 20 weeks minimizes gastrointestinal side effects while building therapeutic efficacy Standard monotherapy reaches a maximum maintenance dose of 4.5 mg weekly after systematic increases Combination protocols (CagriSema) pair cagrilintide with semaglutide for enhanced weight management outcomes Clinical trial data demonstrates approximately 10.8% body weight reduction with monotherapy at 32 weeks Proper injection technique and site rotation are essential for optimal absorption and safety Understanding Cagrilintide: What Health Professionals Need to Know Cagrilintide is a long-acting amylin analogue currently being developed by Novo Nordisk for obesity and type 2 diabetes management

What should I ask my clinician about Retatrutide

The role of increased fatty acid and glucose metabolism, mitochondrial dysfunction, and increased protein acetylation in the DKD pathology (2)

Im especially looking forward to a cruise next year with my family, many of whom I havent seen in a long time, and I feel proud knowing Ill be showing up as a totally different, healthier version of myself